Pathological response and outcome after neoadjuvant chemotherapy with DOC (docetaxel, oxaliplatin, capecitabine) or EOF (epirubicin, oxaliplatin, 5-fluorouracil) for clinical T3-T4 non-metastatic gastric cancer

Roberto Petrioli, Daniele Marrelli, Franco Roviello, Alessia D’Ignazio, Pamela Torre, Martina Chirra, Vinno Savelli, Maria Raffaella Ambrosio, Guido Francini, Natale Calomino,

Surgical Oncology · 2019 · 13 citations · 24 references

DOIFull text

Open access

Concepts

References

24